Close Menu

Infectious Disease

News on research and diagnostic development for pathogenic diseases.

The firm has opened a $10 million Series A financing round that it expects to close in late summer to support running clinical studies for its assay.

The company attributed the revenue decline in part to working capital restraints and long manufacturing lead times, which are being addressed currently.

The firm said it anticipates using the financing for further commercialization and expansion of its infectious disease testing vertical, among other activities.

CEO Prahlad Singh said the firm is developing a PCR- and antibody-based assay for the novel coronavirus 2019-nCoV and is working with the Chinese NMPA.

The company's Lyo-Ready 1-Step RT-qPCR mix is being used by diagnostic labs in China to develop screening assays for the virus.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb
20
Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.

Feb
26
Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.